“Long-Term Efficacy of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: Data from a Pivotal Phase 3 Clinical Trial” (2018) SKIN The Journal of Cutaneous Medicine, 2(S1), p. S9. doi:10.25251/skin.2.supp.9.